Developing a nonendoscopic screening test for Barrett's esophagus

Biomarkers in Medicine

Volumn 5, Issue 3, 2011, Pages 397-404

  Kadri, Sudarshan ^a   Lao Sirieix, Pierre ^a   Fitzgerald, Rebecca C ^a  

^a HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

Author keywords

biomarker; esophageal adenocarcinoma; gastro esophageal reflux disease; screening

Indexed keywords

BARRETT ESOPHAGUS; BIOPSY DEVICE; CAPSULE ENDOSCOPY; ESOPHAGOSCOPY; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MASS SCREENING; NOMOGRAM; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADSORPTION; BARRETT ESOPHAGUS; BIOLOGICAL MARKERS; ENDOSCOPY, GASTROINTESTINAL; HUMANS; PEPTIDES; RISK FACTORS; RNA, MESSENGER;

EID: 79958802530     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.11.40     Document Type: Review

References (71)

1. Ferlay J, Shin HR, Bray F et al.: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127(12), 2893-2917 (2010).
2. Pohl H, Sirovich B, Welch HG: Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol. Biomarkers Prev. 19(6), 1468-1470 (2010).
3. Crew KD, Neugut AI: Epidemiology of upper gastrointestinal malignancies. Semin. Oncol. 31(4), 450-464 (2004). (Pubitemid 39070265)
4. Nguyen AM, Luke CG, Roder D: Comparative epidemiological characteristics of oesophageal adenocarcinoma and other cancers of the oesophagus and gastric cardia. Asian Pac. J. Cancer Prev. 4(3), 225-231 (2003).
5. Van Blankenstein M, Looman CW, Hop WC, Bytzer P: The incidence of adenocarcinoma and squamous cell carcinoma of the esophagus: Barrett's esophagus makes a difference. Am. J. Gastroenterol. 100(4), 766-774 (2005). (Pubitemid 40592364)
6. Younes M, Henson DE, Ertan A, Miller CC: Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand. J. Gastroenterol. 37(12), 1359-1365 (2002). (Pubitemid 36051495)
7. Vizcaino AP, Moreno V, Lambert R, Parkin DM: Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995 Int. J. Cancer 99(6), 860-868 (2002). (Pubitemid 34575705)
8. Sihvo EI, Luostarinen ME, Salo JA: Fate of patients with adenocarcinoma of the esophagus and the esophagogastric junction: a population-based analysis. Am. J. Gastroenterol. 99(3), 419-424 (2004). (Pubitemid 38524117)
9. Bowrey DJ, Griffin SM, Wayman J et al.: Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked. Surg. Endosc. 20(11), 1725-1728 (2006). (Pubitemid 44715537)
10. Enzinger PC, Mayer RJ: Esophageal cancer. N. Engl. J. Med. 349(23), 2241-2252 (2003). (Pubitemid 37485141)
11. Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359(9319), 1727-1733 (2002).
12. Reid BJ, Li X, Galipeau PC Vaughan TL: Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat. Rev. Cancer 10(2), 87-101 (2010).
13. Pohl H, Welch HG: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J. Natl Cancer Inst. 97(2), 142-146 (2005). (Pubitemid 40277094)
14. Peters JH, Clark GW, Ireland AP et al.: Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J. Thorac. Cardiovasc. Surg. 108(5), 813-821 (1994).
15. Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA: Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 122(3), 633-640 (2002). (Pubitemid 34173814)
16. Wilson JM and Jungner YG: [Principles and practice of mass screening for disease]. Bol. Oficina Sanit. Panam. 65(4), 281-393 (1968).
17. Playford RJ: New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut 55(4), 442 (2006).
18. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ: American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 140(3), 1084-1091 (2011).
19. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ: American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 140(3), E18-E52; quiz e13 (2011).
20. Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ: Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 8(3), 235-244 (2009).
21. Cameron AJ: Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol. Clin. North Am. 26(3), 487-494 (1997). (Pubitemid 27453229)
22. Rex DK, Cummings OW, Shaw M et al.: Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125(6), 1670-1677 (2003). (Pubitemid 37500431)
23. Veldhuyzen van Zanten SJ, Thomson AB, Barkun AN et al.: The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy. Aliment Pharmacol. Ther. 23(5), 595-599 (2006).
24. Ronkainen J, Aro P, Storskrubb T et al.: Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129(6), 1825-1831 (2005). (Pubitemid 41772961)
25. Gerson LB, Shetler K, Triadafilopoulos G: Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123(2), 461-467 (2002). (Pubitemid 34827190)
26. van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ: Increasing incidence of Barrett's oesophagus in the general population. Gut 54(8), 1062-1066 (2005). (Pubitemid 41025895)
27. Talley NJ, Vakil N: Guidelines for the management of dyspepsia. Am. J. Gastroenterol. 100(10), 2324-2337 (2005).
28. Winters C Jr, Spurling TJ, Chobanian SJ et al.: Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92(1), 118-124 (1987). (Pubitemid 17207669)
29. Lagergren J, Bergstrom R, Nyren O: Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann. Intern. Med. 130(11), 883-890 (1999). (Pubitemid 29239582)
30. Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340(11), 825-831 (1999). (Pubitemid 29142625)
31. Anderson LA, Watson RG, Murphy SJ et al.: Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J. Gastroenterol. 13(10), 1585-1594 (2007). (Pubitemid 46672669)
32. Zagari RM, Fuccio L, Wallander MA et al.: Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut 57(10), 1354-1359 (2008).
33. Banki F, Demeester SR, Mason RJ et al.: Barrett's esophagus in females: a comparative analysis of risk factors in females and males. Am. J. Gastroenterol. 100(3), 560-567 (2005). (Pubitemid 40487553)
34. Connor MJ, Weston AP, Mayo MS, Sharma P: The prevalence of Barrett's esophagus and erosive esophagitis in patients undergoing upper endoscopy for dyspepsia in a VA population. Dig. Dis. Sci. 49(6), 920-924 (2004). (Pubitemid 39012273)
35. Lin M, Gerson LB, Lascar R, Davila M, Triadafilopoulos G: Features of gastroesophageal reflux disease in women. Am. J. Gastroenterol. 99(8), 1442-1447 (2004). (Pubitemid 39180088)
36. Van Blankenstein M, Looman CW, Kruijshaar ME et al.: Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data. Scand. J. Gastroenterol. 42(3), 308-317 (2007).
37. Cameron AJ, Lomboy CT: Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 103(4), 1241-1245 (1992).
38. Eloubeidi MA, Provenzale D: Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J. Clin. Gastroenterol. 33(4), 306-309 (2001). (Pubitemid 32880970)
39. Spechler SJ: Clinical practice. Barrett's Esophagus. N. Engl. J. Med. 346(11), 836-842 (2002).
40. Cook MB, Greenwood DC, Hardie LJ, Wild CP, Forman D: A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am. J. Gastroenterol. 103(2), 292-300 (2008). (Pubitemid 351248722)
41. Corley DA, Kubo A, Levin TR et al.: Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 133(1), 34-41 (2007). (Pubitemid 47031134)
42. Shaheen NJ, Sharma P, Overholt BF et al.: Radiofrequency ablation in Barrett's esophagus with dysplasia. N. Engl. J. Med. 360(22), 2277-2288 (2009).
43. Pouw RE, Wirths K, Eisendrath P et al.: Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin. Gastroenterol. Hepatol. 8(1), 23-29 (2010).
44. Streitz JM Jr, Andrews CW Jr, Ellis FH Jr: Endoscopic surveillance of Barrett's esophagus. Does it help? J. Thorac. Cardiovasc. Surg. 105(3), 383-387 (1993).
45. Gerson LB, Edson R, Lavori PW, Triadafilopoulos G: Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am. J. Gastroenterol. 96(7), 2005-2012 (2001). (Pubitemid 32660890)
46. Locke GR, Zinsmeister AR, Talley NJ: Can symptoms predict endoscopic findings in GERD? Gastrointest. Endosc. 58(5), 661-670 (2003). (Pubitemid 37370477)
47. Inadomi JM, Sampliner R, Lagergren J et al.: Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann. Intern. Med. 138(3), 176-186 (2003). (Pubitemid 36231623)
48. Soni A, Sampliner RE, Sonnenberg A: Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am. J. Gastroenterol. 95(8), 2086-2093 (2000).
49. Barbiere JM, Lyratzopoulos G: Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review. Gastroenterology 137(6), 1869-1876 (2009).
50. Dumortier J, Napoleon B, Hedelius F et al.: Unsedated transnasal EGD in daily practice: results with 1100 consecutive patients. Gastrointest. Endosc. 57(2), 198-204 (2003). (Pubitemid 36236759)
51. Craig A, Hanlon J, Dent J, Schoeman M: A comparison of transnasal and transoral endoscopy with small-diameter endoscopes in unsedated patients. Gastrointest. Endosc. 49(3 Pt 1), 292-296 (1999). (Pubitemid 29135219)
52. Trevisani L, Cifala V, Sartori S et al.: Unsedated ultrathin upper endoscopy is better than conventional endoscopy in routine outpatient gastroenterology practice: a randomized trial. World J. Gastroenterol. 13(6), 906-911 (2007). (Pubitemid 46470302)
53. Eliakim R, Yassin K, Shlomi I, Suissa A, Eisen GM: A novel diagnostic tool for detecting oesophageal pathology: the PillCam oesophageal video capsule. Aliment Pharmacol. Ther. 20(10), 1083-1089 (2004). (Pubitemid 39657941)
54. Lin OS, Schembre DB, Mergener K et al.: Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux. Gastrointest. Endosc. 65(4), 577-583 (2007). (Pubitemid 46454272)
55. Ramirez FC, Akins R, Shaukat M: Screening of Barrett's esophagus with string-capsule endoscopy: a prospective blinded study of 100 consecutive patients using histology as the criterion standard. Gastrointest. Endosc. 68(1), 25-31 (2008).
56. Falk GW, Chittajallu R, Goldblum JR et al.: Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology. Gastroenterology 112(6), 1787-1797 (1997). (Pubitemid 27240762)
57. Saad RS, Mahood LK, Clary KM et al.: Role of cytology in the diagnosis of Barrett's esophagus and associated neoplasia. Diagn. Cytopathol. 29(3), 130-135 (2003). (Pubitemid 37071529)
58. Hardwick RH, Morgan RJ, Warren BF, Lott M, Alderson D: Brush cytology in the diagnosis of neoplasia in Barrett's esophagus. Dis. Esophagus 10(4), 233-237 (1997). (Pubitemid 28039622)
59. Lao-Sirieix P, Rous B, O'Donovan M et al.: Non-endoscopic immunocytological screening test for Barrett's oesophagus. Gut 56(7), 1033-1034 (2007). (Pubitemid 46999107)
60. Rygiel AM, Milano F, Ten Kate FJ et al.: Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens. Genes Chromosomes Cancer 47(5), 396-404 (2008). (Pubitemid 351451794)
61. Lao-Sirieix P, Lovat L, Fitzgerald RC: Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance. Clin. Cancer Res. 13(2 Pt 1), 659-665 (2007). (Pubitemid 46225374)
62. Fahmy M, Skacel M, Gramlich TL et al.: Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens. Mod. Pathol. 17(5), 588-596 (2004). (Pubitemid 38868427)
63. Rygiel AM, van Baal JW, Milano F et al.: Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population. Cancer 109(10), 1980-1988 (2007). (Pubitemid 46744191)
64. MacLennan AJ, Orringer MB, Beer DG: Identification of intestinal-type Barrett's metaplasia by using the intestine-specific protein villin and esophageal brush cytology. Mol. Carcinog. 24(2), 137-143 (1999). (Pubitemid 29115916)
65. Lao-Sirieix P, Boussioutas A, Kadri SR et al.: Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic. Gut 58(11), 1451-1459 (2009).
66. Kadri SR, Lao-Sirieix P, O'Donovan M et al.: Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ 341c4372 (2010).
67. Bunting PS: Screening for prostate cancer with prostate-specific antigen: beware the biases. Clin. Chim. Acta 315(1-2), 71-97 (2002). (Pubitemid 33145250)
68. Towler B, Irwig L, Glasziou P et al.: A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 317(7158), 559-565 (1998). (Pubitemid 28395924)
69. Nanda K, McCrory DC, Myers ER et al.: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann. Intern. Med. 132(10), 810-819 (2000). (Pubitemid 30317797)
70. Prach AT, MacDonald TA, Hopwood DA, Johnston DA: Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? Lancet 350(9082), 933 (1997).
71. Conio M, Cameron AJ, Romero Y et al.: Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 48(3), 304-309 (2001). (Pubitemid 32269555)